Is ESAIY or ORCC a better dividend investment in 2026?

ESAIY currently yields 3.13% with a 5% 5-year dividend growth rate. ORCC yields 4.00% with 5% growth. The better choice depends on your goal: ORCC offers higher current income.

What is the dividend yield difference between ESAIY and ORCC?

ESAIY has a forward dividend yield of 3.13% ($0.24/share annually). ORCC yields 4.00% ($2.00/share annually). The yield gap is 0.87 percentage points.

Home › Compare › ESAIY vs ORCC

ESAIY vs ORCC: Dividend Comparison 2026

ESAIY yields 3.13% · ORCC yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ORCC wins by $3.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ESAIY

● Live price

3.13%

Share price

$7.66

Annual div

$0.24

5Y div CAGR

0.4%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.6K

Annual income

$400.49

Full ESAIY calculator →

ORCC

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full ORCC calculator →

Portfolio growth — ESAIY vs ORCC

📍 ORCC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ESAIY	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ESAIY + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ESAIY pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ESAIY

Annual income on $10K today (after 15% tax)

$266.34/yr

After 10yr DRIP, annual income (after tax)

$340.42/yr

ORCC

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, ORCC beats the other by $423.90/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ESAIY + ORCC for your $10,000?

ESAIY: 50%ORCC: 50%

100% ORCC50/50100% ESAIY

Portfolio after 10yr

$26.3K

Annual income

$649.85/yr

Blended yield

2.47%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

ESAIY

No analyst data

Altman Z

3.0

Piotroski

7/9

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

-68.0% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ESAIY buys

ORCC buys

No recent congressional trades found for ESAIY or ORCC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricESAIYORCC

Forward yield	3.13%	4.00% ✓
Annual dividend / share	$0.24	$2.00 ✓
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0.4%	5% ✓
Portfolio after 10y	$24.6K	$28.0K ✓
Annual income after 10y	$400.49	$899.19 ✓
Total dividends collected	$3.6K	$6.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: ESAIY vs ORCC ($10,000, DRIP)

Year	ESAIY Portfolio	ESAIY Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1← crossover	$11,015	$314.60	$11,120	$420.00	$105.00 → ORCC
2	$12,111	$325.14	$12,357	$458.31	$246.00 → ORCC
3	$13,294	$335.45	$13,721	$499.76	$427.00 → ORCC
4	$14,570	$345.51	$15,227	$544.58	$657.00 → ORCC
5	$15,945	$355.31	$16,885	$593.02	$940.00 → ORCC
6	$17,426	$364.87	$18,713	$645.34	$1.3K → ORCC
7	$19,020	$374.16	$20,724	$701.81	$1.7K → ORCC
8	$20,735	$383.19	$22,938	$762.73	$2.2K → ORCC
9	$22,578	$391.97	$25,372	$828.41	$2.8K → ORCC
10	$24,559	$400.49	$28,047	$899.19	$3.5K → ORCC

ESAIY vs ORCC: Complete Analysis 2026

ESAIY — Stock

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; Methycobal for the treatment of peripheral neuropathy; and Halaven, an anticancer agent for the treatment of breast cancer. The company also provides Jyseleca, a janus kinase inhibitor; Elental, a branched-chain amino acid preparation; Goofice and Movicol for chronic constipation; Fycompa, an antiepileptic agent; Pariet, a proton-pump inhibitor; Aricept, for Alzheimer's disease/Dementia with Lewy bodies; and Chocola BB plus for the preparation vitamin B2. It has strategic collaboration with Bristol Myers Squibb for the co-development and co-commercialization of farletuzumab ecteribulin antibody drug conjugate. Eisai Co., Ltd. was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.

Full ESAIY Calculator →

ORCC — BDC

ORCC is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in ORCC shares.

Full ORCC Calculator →

📬

Get this ESAIY vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ESAIY vs SCHD ESAIY vs JEPI ESAIY vs O ESAIY vs KO ESAIY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.